Chapman RW - Search Results

1

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG); Levy C. Lynch KD, et al. Among authors: chapman rw. Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14. Clin Gastroenterol Hepatol. 2020. PMID: 31100458 Free PMC article.

2

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E. Bansi DS, et al. Eur J Gastroenterol Hepatol. 1997 Jun;9(6):575-80. doi: 10.1097/00042737-199706000-00005. Eur J Gastroenterol Hepatol. 1997. PMID: 9222729 Clinical Trial.

3

Aetiopathogenesis of primary sclerosing cholangitis.

Cullen S, Chapman R. Cullen S, et al. Best Pract Res Clin Gastroenterol. 2001 Aug;15(4):577-89. doi: 10.1053/bega.2001.0206. Best Pract Res Clin Gastroenterol. 2001. PMID: 11492969 Review.

4

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

5

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol. 2002 Oct;37(10):1205-11. doi: 10.1080/003655202760373434. Scand J Gastroenterol. 2002. PMID: 12408527

6

The management of primary sclerosing cholangitis.

Chapman RW. Chapman RW. Curr Gastroenterol Rep. 2003 Feb;5(1):9-17. doi: 10.1007/s11894-003-0004-z. Curr Gastroenterol Rep. 2003. PMID: 12530943 Review.

7

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP. Yang X, et al. Among authors: chapman rw. J Hepatol. 2004 Mar;40(3):375-9. doi: 10.1016/j.jhep.2003.11.009. J Hepatol. 2004. PMID: 15123348

8

Sclerosing cholangitis.

Björnsson E, Chapman RW. Björnsson E, et al. Among authors: chapman rw. Curr Opin Gastroenterol. 2003 May;19(3):270-5. doi: 10.1097/00001574-200305000-00011. Curr Opin Gastroenterol. 2003. PMID: 15703568

9

Sclerosing cholangitis.

MacFaul GR, Chapman RW. MacFaul GR, et al. Among authors: chapman rw. Curr Opin Gastroenterol. 2004 May;20(3):275-80. doi: 10.1097/00001574-200405000-00013. Curr Opin Gastroenterol. 2004. PMID: 15703653

10

Fatigue is not a specific symptom in patients with primary biliary cirrhosis.

Björnsson E, Simren M, Olsson R, Chapman RW. Björnsson E, et al. Among authors: chapman rw. Eur J Gastroenterol Hepatol. 2005 Mar;17(3):351-7. doi: 10.1097/00042737-200503000-00015. Eur J Gastroenterol Hepatol. 2005. PMID: 15716661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page